SSY Group Limited Stock Price
Last Done:
SGD 9.39
+0.12 (+1.31%)
β’ Login required for live price
Open: --
High: --
Low: --
Prev Close: --
Login to unlock live stock price, change %, and intraday data.
Login to View
Market: HKEX |
Currency: HKD
Address: Central Plaza
SSY Group Limited, an investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; food, beverages, and catering businesses; and production and sale of methylamine. It sells its products under the Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was founded in 1999 and is headquartered in Wan Chai, Hong Kong.
Show more
π SSY Group Limited Historical Chart
π Statistics
-
Analyst 1 Year Price Target:
$3.08
-
Upside/Downside from Analyst Target:
2.67%
-
Broker Call:
2
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
<0%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
<0%
-
Upcoming Earnings Date:
2026-08-27
π° Dividend History
No dividend history available.
π
Earnings & EPS History for SSY Group Limited
| Date | Reported EPS |
|---|
| 2026-08-27 (estimated upcoming) | - |
π° Latest Corporate News
March 19, 2026 4:30 pm | HKEX
SSY Group Limited Announces Regulatory Approval for Calcium ...
March 16, 2026 12:02 pm | HKEX
SSY Group Limited: Bumetanide Bulk Drug Approval Update
...
March 13, 2026 4:56 pm | HKEX
SSY Group Limited: Key Product Approval Update
SSY Gro...
March 13, 2026 4:30 pm | HKEX
SSY Group Limited Announces Key Product Development Breakthr...
March 6, 2026 12:00 pm | HKEX
SSY Group Limited Obtains Drug Approval: Potential Share Pri...
π° Related News & Research
π View more Reports